These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 3799324

  • 1. Capillary density of the cardiomyopathic Syrian hamster.
    Figulla HR, Vetterlein F, Glaubitz M, Kreuzer H.
    Adv Exp Med Biol; 1986; 200():359-65. PubMed ID: 3799324
    [No Abstract] [Full Text] [Related]

  • 2. Inhomogenous capillary flow and its prevention by verapamil and hydralazine in the cardiomyopathic Syrian hamster.
    Figulla HR, Vetterlein F, Glaubitz M, Kreuzer H.
    Circulation; 1987 Jul; 76(1):208-16. PubMed ID: 2439233
    [Abstract] [Full Text] [Related]

  • 3. Effects of lercanidipine on coronary reactivity and myocardial remodeling in transition to heart failure in cardiomyopathic hamsters.
    Massicotte J, Viens A, Yao MH, Leonardi A, Sironi G, Wang H, Dumont L.
    Acta Pharmacol Sin; 2003 Mar; 24(3):199-206. PubMed ID: 12617766
    [Abstract] [Full Text] [Related]

  • 4. Histological and electron microscopic stereological study of the myocardium of newborn genetically cardiomyopathic hamsters.
    Kidd PM, Jones AL, Lemanski LF, Rudolph A, Allen L.
    J Ultrastruct Res; 1981 Aug; 76(2):107-19. PubMed ID: 7299892
    [No Abstract] [Full Text] [Related]

  • 5. Effects of L-carnitine and verapamil on myocardial carnitine concentration and histopathology of Syrian hamster BIO 14.6.
    Yamashita T, Kobayashi A, Yamazaki N, Miura K, Shirasawa H.
    Cardiovasc Res; 1986 Aug; 20(8):614-20. PubMed ID: 3791351
    [Abstract] [Full Text] [Related]

  • 6. Vitamin E deficiency has a pathological role in myocytolysis in cardiomyopathic Syrian hamster (BIO14.6).
    Sakanashi T, Sako S, Nozuhara A, Adachi K, Okamoto T, Koga Y, Toshima H.
    Biochem Biophys Res Commun; 1991 Nov 27; 181(1):145-50. PubMed ID: 1958182
    [Abstract] [Full Text] [Related]

  • 7. Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis.
    Factor SM, Minase T, Cho S, Dominitz R, Sonnenblick EH.
    Circulation; 1982 Aug 27; 66(2):342-54. PubMed ID: 7094244
    [Abstract] [Full Text] [Related]

  • 8. [The small focal hypoxic myocardial necrosis].
    Poche R.
    Dtsch Med Wochenschr; 1969 Sep 12; 94(37):1851-5. PubMed ID: 5356317
    [No Abstract] [Full Text] [Related]

  • 9. Capillary density and leukocyte adhesion in hamsters with hereditary cardiomyopathy.
    Colantuoni A, Coppini G, Bertuglia S.
    Microvasc Res; 1998 Sep 12; 56(2):85-94. PubMed ID: 9756731
    [Abstract] [Full Text] [Related]

  • 10. Myocyte structure, function, and calcium kinetics in the cardiomyopathic hamster heart.
    Sen LY, O'Neill M, Marsh JD, Smith TW.
    Am J Physiol; 1990 Nov 12; 259(5 Pt 2):H1533-43. PubMed ID: 2240250
    [Abstract] [Full Text] [Related]

  • 11. Intrinsic connective tissue abnormalities in the heart muscle of cardiomyopathic Syrian hamsters.
    Cohen-Gould L, Robinson TF, Factor SM.
    Am J Pathol; 1987 May 12; 127(2):327-34. PubMed ID: 3578490
    [Abstract] [Full Text] [Related]

  • 12. Myocardial subcellular fractionation studies on cardiomyopathic Syrian hamsters.
    Fitchett DH, Scott J, Stephens HR, Peters TJ.
    Cardiovasc Res; 1979 May 12; 13(5):260-8. PubMed ID: 476746
    [Abstract] [Full Text] [Related]

  • 13. Role of increased alpha 1-adrenergic activity in cardiomyopathic Syrian hamster.
    Kagiya T, Hori M, Iwakura K, Iwai K, Watanabe Y, Uchida S, Yoshida H, Kitabatake A, Inoue M, Kamada T.
    Am J Physiol; 1991 Jan 12; 260(1 Pt 2):H80-8. PubMed ID: 1671540
    [Abstract] [Full Text] [Related]

  • 14. Alterations in cardiac SR Ca(2+)-release channels during development of heart failure in cardiomyopathic hamsters.
    Ueyama T, Ohkusa T, Hisamatsu Y, Nakamura Y, Yamamoto T, Yano M, Matsuzaki M.
    Am J Physiol; 1998 Jan 12; 274(1):H1-7. PubMed ID: 9458845
    [Abstract] [Full Text] [Related]

  • 15. Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy.
    Sonnenblick EH, Fein F, Capasso JM, Factor SM.
    Am J Cardiol; 1985 Jan 25; 55(3):179B-184B. PubMed ID: 3881912
    [Abstract] [Full Text] [Related]

  • 16. [No reflow phenomenon of the heart and microcirculatory coronary insufficiency].
    Poche R.
    Pathologe; 1984 Jul 25; 5(4):204-11. PubMed ID: 6483799
    [No Abstract] [Full Text] [Related]

  • 17. Cardiomyopathic Syrian hamster: a possible model of human disease.
    Gertz EW.
    Prog Exp Tumor Res; 1972 Jul 25; 16():242-60. PubMed ID: 4261129
    [No Abstract] [Full Text] [Related]

  • 18. Size and shape of enzymatically isolated ventricular myocytes from rats and cardiomyopathic hamsters.
    Sorenson AL, Tepper D, Sonnenblick EH, Robinson TF, Capasso JM.
    Cardiovasc Res; 1985 Dec 25; 19(12):793-9. PubMed ID: 4084937
    [Abstract] [Full Text] [Related]

  • 19. Effects of carbon monoxide on myocardium. Ultrastructural changes in rabbits after moderate, chronic exposure.
    Kjeldsen K, Thomsen HK, Astrup P.
    Circ Res; 1974 Mar 25; 34(3):339-48. PubMed ID: 4818758
    [No Abstract] [Full Text] [Related]

  • 20. Studies of nuclear proteins in the heart of the cardiomyopathic Syrian hamster--phosphorylation of histones.
    Liew CC, Sole MJ.
    J Mol Cell Cardiol; 1978 Sep 25; 10(9):847-55. PubMed ID: 152360
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.